xanthenes has been researched along with Ovarian Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Huang, L; Li, T; Lin, LG; Liu, JL; Liu, QY; Lu, JJ; Qiang, WA; Wang, Y; Xu, XH | 1 |
| Jiang, H; Sheng, WJ; Wu, DL; Zheng, JH | 1 |
| Abd Elmageed, ZY; Azam, GA; Braley, P; Fathi, IM; Gaur, RL; Nguyen, L; Ouhtit, A; Raj, MH; Rao, PN; Zhou, J | 1 |
| Darroudi, F; Duke, CC; Smit, NP; Trimbos, BJ; van Haaften, C; van Haard, PM; Weerheim, AM | 1 |
| Chan, MM; Fong, D; Heverling, H; Holmes, WF; Soprano, KJ | 1 |
| Cowden, RR; Curtis, SK | 1 |
| De Bruijn, EA; Elst, HE; Gheuens, EE; van der Heyden, SA; Van Oosterom, AT | 1 |
| Baguley, BC; Cao, Z; Ching, LM; Joseph, WR; Marshall, ES; Mountjoy, KG | 1 |
| Baguley, BC; Cao, Z; Ching, LM; Jameson, MB; Kieda, C; Zwain, S | 1 |
| Leeper, DB; Park, CH; Rowley, R; Thakur, ML | 1 |
1 trial(s) available for xanthenes and Ovarian Neoplasms
| Article | Year |
|---|---|
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Blotting, Northern; Breast Neoplasms; Cells, Cultured; Chemokine CXCL10; Chemokines, CXC; Colonic Neoplasms; Endothelium, Vascular; Female; Humans; Interferons; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 2002 |
9 other study(ies) available for xanthenes and Ovarian Neoplasms
| Article | Year |
|---|---|
Garcinone E induces apoptosis and inhibits migration and invasion in ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Humans; Molecular Structure; Ovarian Neoplasms; Protein Serine-Threonine Kinases; Signal Transduction; Xanthenes; Xanthones | 2017 |
Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Migration Assays; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Oxazines; Rats; Signal Transduction; STAT3 Transcription Factor; Survivin; Vascular Endothelial Growth Factor A; Xanthenes | 2013 |
Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis Regulatory Proteins; Cell Cycle; Drug Synergism; Female; Humans; Indoles; Nitric Oxide; Ovarian Neoplasms; Oxazines; Resveratrol; Staining and Labeling; Stilbenes; Xanthenes | 2008 |
Potent cytotoxic effects of Calomeria amaranthoides on ovarian cancers.
Topics: Acrylates; Animals; Antineoplastic Agents; Asteraceae; Australia; Cell Line, Tumor; Cell Survival; Cisplatin; Female; Humans; Lactones; Mice; Mice, Nude; Ovarian Neoplasms; Oxazines; Plant Extracts; Sesquiterpenes; Xanthenes | 2011 |
Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents.
Topics: Antineoplastic Agents; Cell Death; Cell Division; Cell Survival; Cisplatin; Coloring Agents; Curcumin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Flavonoids; Growth Inhibitors; Humans; Inactivation, Metabolic; Interleukin-6; Ovarian Neoplasms; Oxazines; Phenols; Polymers; Quercetin; Tumor Cells, Cultured; Xanthenes | 2003 |
Supravital experiments with Pyronin Y, a fluorochrome of mitochondria and nucleic acids.
Topics: Animals; Cricetinae; Cricetulus; Female; Fluorescent Dyes; Grasshoppers; Male; Microscopy, Electron; Microscopy, Fluorescence; Mitochondria; Neoplasms, Experimental; Ovarian Neoplasms; Pyronine; RNA; Spermatozoa; Xanthenes | 1983 |
Comparison of daunorubicin and Fluo-3 for detection of multidrug resistance in human tumor cells.
Topics: Aniline Compounds; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Xanthenes | 1997 |
Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Lipopolysaccharides; Liver; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; RNA, Messenger; Spleen; Stimulation, Chemical; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1999 |
Radioiodinated rhodamine-123: preparation and preliminary evaluation as an agent for tumor scintigraphy.
Topics: Adenocarcinoma; Animals; Cricetinae; Female; Iodine Radioisotopes; Isotope Labeling; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitochondria; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Radionuclide Imaging; Rhodamine 123; Rhodamines; Sarcoma, Experimental; Tissue Distribution; Xanthenes | 1988 |